EGFR over-expression and activation in high HER2, ER negative breast cancer cell line induces trastuzumab resistance

By Dua Rajiv  

Breast Cancer Research and Treatment, Vol. 122, Iss. 3, 2010-08 ,pp. : 685-697

Springer Publishing Company

Access to resources Recommend Favorite

Overexpression of Bmi-1 contributes to the invasion and metastasis of hepatocellular carcinoma by increasing the expression of matrix metalloproteinase (MMP)2, MMP-9 and vascular endothelial growth factor via the PTEN/PI3K/Akt pathway

By                        

International Journal of Oncology, Vol. 43, Iss. 3, 2013-01 ,pp. : 793-802

Spandidos Publications

Access to resources Recommend Favorite

Loss of androgen receptor associated protein 70 (ARA70) expression in a subset of HER2-positive breast cancers

By Kollara A.  

Breast Cancer Research and Treatment, Vol. 67, Iss. 3, 2001-06 ,pp. : 245-253

Springer Publishing Company

Access to resources Recommend Favorite

Loss of heterozygosity at BRCA2 in a ductal carcinoma in situ and three invasive breast carcinomas in a family with a germline BRCA2 mutation

By Thomassen Mads  

Breast Cancer Research and Treatment, Vol. 87, Iss. 3, 2004-10 ,pp. : 273-276

Springer Publishing Company

Access to resources Recommend Favorite

Phase I–II study of the farnesyl transferase inhibitor tipifarnib plus sequential weekly paclitaxel and doxorubicin–cyclophosphamide in HER2/neu-negative inflammatory carcinoma and non-inflammatory estrogen receptor-positive breast carcinoma

By Andreopoulou Eleni   Vigoda Ivette   Valero Vicente   Hershman Dawn   Raptis George   Vahdat Linda   Han Hyo   Wright John   Pellegrino Christine   Cristofanilli Massimo   Alvarez Ricardo   Fehn Karen   Fineberg Susan   Sparano Joseph  

Breast Cancer Research and Treatment, Vol. 141, Iss. 3, 2013-10 ,pp. : 429-435

Springer Publishing Company

Access to resources Recommend Favorite